1. EVOQ Nano's EVQ-218 nanoparticle is designed to combat antibiotic-resistant bacteria without triggering resistance. 2. The nanoparticle disrupts bacterial metabolic processes by sequestering sulfur, preventing the activation of mutations that lead to antimicrobial resistance. 3. EVQ-218 is being developed for use in therapeutic antimicrobial solutions, medical devices, and textiles, aiming to address the growing threat of antimicrobial resistance.
Related Articles
- Oxalic Acid Triggers Gadolinium Nanoparticle Formation in Human Tissues7 months ago
 - Supercomputer Modeling Reveals Critical Shape Changes in Nanoparticle Seed Formation7 months ago
 - Bio-Based Nanocomposite Coating for Urinary Catheters to Prevent CAUTIs7 months ago
 - Novel Acoustofluidic Method for High-Efficiency Nanoparticle Delivery into Cells8 months ago
 - Engineered DNA-Nanoparticle Motors Achieve Motor Protein Speeds10 months ago
 - Electrochemistry Unlocks Unusual Nanoparticle12 months ago
 - Real-Time Imaging Provides a New Perspective on Nanoparticle Growth12 months ago
 - Nanoparticle-Based Remediation of Chromium-Contaminated Groundwaterabout 1 year ago
 - Nanoparticle Technology Offers Hope for Atherosclerosis Patientsabout 1 year ago